Opinions, editorials, op-eds, commentary and analysis on today's news

Aug 15, 2022 18:49 PM

Editorial: Promoting Greater Fiscal Discipline in Government
Greater government fiscal discipline involves complex redistributions of benefits, but in the end it will improve China’s national governance capability
Aug 12, 2022 18:24 PM

China Green Bulletin: Beijing Says Climate Talks Halt Is Washington’s Fault
China creates principles to streamline green bond market, government agencies expect industrial carbon emissions to peak by 2030 target
Aug 10, 2022 18:32 PM

Opinion: The Two Weaknesses of China’s Economy
It will be difficult for the country to hit its annual growth target with consumer spending still sluggish and the real estate market in the doldrums
Aug 09, 2022 04:41 AM

Editorial: Preventing Inflation and Stagnation, With Focus on Stagnation
China needs to effectively implement already-issued policies to bolster domestic demand and relief measures targeting market entities
Aug 06, 2022 04:00 AM

Analysis: How New Approval Standards May Spur Chinese Covid Pills
Regulators move the goal posts for determining whether a new drug works, reflecting dramatic evolution of the coronavirus
Aug 01, 2022 19:52 PM

Editorial: China Has to Address Its Shrinking Population
While the country’s population dividend is waning, China can improve its efficiency and systems to turbocharge its economic and social development
Jul 29, 2022 20:08 PM

Wang Tao: Politburo Meeting Signals Relaxed Stance on GDP Target
The much-awaited July meeting called for the best result possible, a sign that the government is de-emphasizing the ambitious growth goal set in March
Jul 29, 2022 17:29 PM

China Green Bulletin: Energy Security Clashes With Emissions Target
Nation plans to pilot advanced energy storage schemes, Shanghai and Guangzhou roll out local carbon policies
Jul 27, 2022 17:32 PM

Opinion: AI and Open Medical Data Are the Keys to Solving Global Health Inequity
Global health disparities will improve or worsen depending on how much data researchers can access
Jul 27, 2022 04:27 AM

Analysis: How Azvudine Became China’s First Approved Homegrown Covid Pill
Little-known Genuine Biotech’s AIDS drug turns out to help Covid patients and may turn into a multibillion-dollar product
Jul 26, 2022 19:30 PM

Fisher: Don't Let Cynics Fool You About China’s Stock Rally
The pessimism that has persisted despite the 33.6% jump in Chinese stocks since mid-March has undercut expectations, leaving the market primed for even bigger gains in the future
Jul 25, 2022 19:19 PM

Editorial: How to ‘Lubricate’ the Frictions in China’s Labor Market
Markets and reform play fundamental roles in fixing the country’s unemployment problem
Jul 22, 2022 18:29 PM

China Green Bulletin: Poyang Lake Project Ignites Environmental Concerns
Beijing seeks to strengthen green cooperation with U.S., China to boost construction of EV charging stations on highways
Jul 18, 2022 18:13 PM

Editorial: Promoting the Integration of Migrant Workers Into Cities
The mismatch between supply and demand in household registration has become the most acute issue in the urbanization process
Jul 15, 2022 15:58 PM

China Green Bulletin: Beijing Plans to Bolster Green Construction
Policymakers seek a better way to track ‘dual carbon’ goals, China to offer tax incentives for green development
Jul 14, 2022 16:18 PM

Opinion: Why Fixing Global Supply Chains May Take a While
China will not be replaced as the world’s manufacturing hub anytime soon as it will take years, if not decades, for large parts to relocate
Jul 13, 2022 18:03 PM

Opinion: The Hard-Won Wisdom of Famed Lawyer Zhang Sizhi
Zhang Sizhi died at the age of 95 after a lifetime of contributions to the legal profession. His career mirrored the fate of his country
Jul 11, 2022 19:55 PM

Editorial: Put an End to Covid Discrimination
To minimize the social and economic damage from the pandemic, China needs to take rules-based, scientific and targeted control measures to better balance Covid controls and economic growth
Jul 08, 2022 05:06 AM

Analysis: The Post-Pandemic Future of China’s Vaccine Industry
While profits from Covid shots could fuel expansion, vaccine makers will be bucking a public health system that’s been starved of resources
Jul 07, 2022 21:35 PM

Chas Freeman: U.S.’ ‘Strategic Ambiguity’ Over Taiwan Remains Alive and Well in Practice
Veteran American diplomat says that policy for the region is under siege from political forces determined to take a more belligerent stance